CERAGON NETWORKS LTD (CRNT) Fundamental Analysis & Valuation

NASDAQ:CRNT • IL0010851660

Current stock price

2.37 USD
+0.03 (+1.28%)
Last:

This CRNT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. CRNT Profitability Analysis

1.1 Basic Checks

  • In the past year CRNT was profitable.
  • CRNT had a positive operating cash flow in the past year.
  • In multiple years CRNT reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: CRNT reported negative operating cash flow in multiple years.
CRNT Yearly Net Income VS EBIT VS OCF VS FCFCRNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 0.43%, CRNT is in line with its industry, outperforming 53.19% of the companies in the same industry.
  • CRNT has a Return On Equity of 0.81%. This is comparable to the rest of the industry: CRNT outperforms 55.32% of its industry peers.
  • CRNT has a better Return On Invested Capital (6.90%) than 76.60% of its industry peers.
Industry RankSector Rank
ROA 0.43%
ROE 0.81%
ROIC 6.9%
ROA(3y)0.75%
ROA(5y)-1.82%
ROE(3y)0.89%
ROE(5y)-3.97%
ROIC(3y)N/A
ROIC(5y)N/A
CRNT Yearly ROA, ROE, ROICCRNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

  • CRNT has a Profit Margin of 0.38%. This is comparable to the rest of the industry: CRNT outperforms 51.06% of its industry peers.
  • CRNT's Operating Margin of 6.32% is fine compared to the rest of the industry. CRNT outperforms 70.21% of its industry peers.
  • CRNT's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 34.98%, CRNT is doing worse than 63.83% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CRNT has remained more or less at the same level.
Industry RankSector Rank
OM 6.32%
PM (TTM) 0.38%
GM 34.98%
OM growth 3Y71.41%
OM growth 5Y22.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.77%
GM growth 5Y0.06%
CRNT Yearly Profit, Operating, Gross MarginsCRNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

3

2. CRNT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CRNT is destroying value.
  • CRNT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CRNT Yearly Shares OutstandingCRNT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CRNT Yearly Total Debt VS Total AssetsCRNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • CRNT has an Altman-Z score of 1.46. This is a bad value and indicates that CRNT is not financially healthy and even has some risk of bankruptcy.
  • CRNT has a Altman-Z score of 1.46. This is comparable to the rest of the industry: CRNT outperforms 53.19% of its industry peers.
  • CRNT has a debt to FCF ratio of 7.68. This is a slightly negative value and a sign of low solvency as CRNT would need 7.68 years to pay back of all of its debts.
  • CRNT's Debt to FCF ratio of 7.68 is in line compared to the rest of the industry. CRNT outperforms 46.81% of its industry peers.
  • CRNT has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.18, CRNT is in line with its industry, outperforming 40.43% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 7.68
Altman-Z 1.46
ROIC/WACC0.76
WACC9.08%
CRNT Yearly LT Debt VS Equity VS FCFCRNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 1.81 indicates that CRNT should not have too much problems paying its short term obligations.
  • The Current ratio of CRNT (1.81) is worse than 65.96% of its industry peers.
  • A Quick Ratio of 1.36 indicates that CRNT should not have too much problems paying its short term obligations.
  • CRNT has a worse Quick ratio (1.36) than 65.96% of its industry peers.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.36
CRNT Yearly Current Assets VS Current LiabilitesCRNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2

3. CRNT Growth Analysis

3.1 Past

  • CRNT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -75.61%.
EPS 1Y (TTM)-75.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-77.78%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-23.01%

3.2 Future

  • Based on estimates for the next years, CRNT will show a very strong growth in Earnings Per Share. The EPS will grow by 48.34% on average per year.
  • The Revenue is expected to grow by 6.87% on average over the next years.
EPS Next Y65.75%
EPS Next 2Y50.56%
EPS Next 3Y48.34%
EPS Next 5YN/A
Revenue Next Year7.05%
Revenue Next 2Y6.87%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

CRNT Yearly Revenue VS EstimatesCRNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
CRNT Yearly EPS VS EstimatesCRNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.1 -0.1 0.2 0.3 0.4

6

4. CRNT Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 23.70, the valuation of CRNT can be described as rather expensive.
  • Based on the Price/Earnings ratio, CRNT is valued a bit cheaper than the industry average as 72.34% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 26.91. CRNT is around the same levels.
  • The Price/Forward Earnings ratio is 14.30, which indicates a correct valuation of CRNT.
  • CRNT's Price/Forward Earnings ratio is rather cheap when compared to the industry. CRNT is cheaper than 91.49% of the companies in the same industry.
  • CRNT is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 23.7
Fwd PE 14.3
CRNT Price Earnings VS Forward Price EarningsCRNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CRNT is valued cheaply inside the industry as 97.87% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRNT is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 52.75
EV/EBITDA 4.57
CRNT Per share dataCRNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

  • CRNT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CRNT's earnings are expected to grow with 48.34% in the coming years.
PEG (NY)0.36
PEG (5Y)N/A
EPS Next 2Y50.56%
EPS Next 3Y48.34%

0

5. CRNT Dividend Analysis

5.1 Amount

  • CRNT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CRNT Fundamentals: All Metrics, Ratios and Statistics

CERAGON NETWORKS LTD

NASDAQ:CRNT (4/10/2026, 10:52:02 AM)

2.37

+0.03 (+1.28%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)02-17
Earnings (Next)05-05
Inst Owners19.3%
Inst Owner Change0%
Ins Owners13.85%
Ins Owner Change6.57%
Market Cap213.04M
Revenue(TTM)N/A
Net Income(TTM)1.39M
Analysts81.67
Price Target4.85 (104.64%)
Short Float %0.27%
Short Ratio0.49
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-30.52%
Min EPS beat(2)-35.18%
Max EPS beat(2)-25.86%
EPS beat(4)1
Avg EPS beat(4)-12.46%
Min EPS beat(4)-35.18%
Max EPS beat(4)17.65%
EPS beat(8)4
Avg EPS beat(8)4.5%
EPS beat(12)6
Avg EPS beat(12)8.41%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-5.56%
Min Revenue beat(2)-11.53%
Max Revenue beat(2)0.4%
Revenue beat(4)2
Avg Revenue beat(4)-2.82%
Min Revenue beat(4)-11.53%
Max Revenue beat(4)0.4%
Revenue beat(8)3
Avg Revenue beat(8)-1.75%
Revenue beat(12)6
Avg Revenue beat(12)-0.89%
Revenue beat(16)6
Avg Revenue beat(16)-1.33%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-33.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-10.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.61%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.65%
Valuation
Industry RankSector Rank
PE 23.7
Fwd PE 14.3
P/S 0.59
P/FCF 52.75
P/OCF 9.83
P/B 1.24
P/tB 1.54
EV/EBITDA 4.57
EPS(TTM)0.1
EY4.22%
EPS(NY)0.17
Fwd EY6.99%
FCF(TTM)0.04
FCFY1.9%
OCF(TTM)0.24
OCFY10.17%
SpS4.04
BVpS1.91
TBVpS1.54
PEG (NY)0.36
PEG (5Y)N/A
Graham Number2.08
Profitability
Industry RankSector Rank
ROA 0.43%
ROE 0.81%
ROCE 11.64%
ROIC 6.9%
ROICexc 8.5%
ROICexgc 10.39%
OM 6.32%
PM (TTM) 0.38%
GM 34.98%
FCFM 1.11%
ROA(3y)0.75%
ROA(5y)-1.82%
ROE(3y)0.89%
ROE(5y)-3.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y93.38%
ROICexgc growth 5Y31.98%
ROICexc growth 3Y86.61%
ROICexc growth 5Y29.42%
OM growth 3Y71.41%
OM growth 5Y22.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.77%
GM growth 5Y0.06%
F-Score5
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 7.68
Debt/EBITDA 0.85
Cap/Depr 129.1%
Cap/Sales 4.85%
Interest Coverage 250
Cash Conversion 59.18%
Profit Quality 290.37%
Current Ratio 1.81
Quick Ratio 1.36
Altman-Z 1.46
F-Score5
WACC9.08%
ROIC/WACC0.76
Cap/Depr(3y)125.95%
Cap/Depr(5y)101.34%
Cap/Sales(3y)4.03%
Cap/Sales(5y)3.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-75.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-77.78%
EPS Next Y65.75%
EPS Next 2Y50.56%
EPS Next 3Y48.34%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-23.01%
Revenue Next Year7.05%
Revenue Next 2Y6.87%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-41.62%
EBIT growth 3Y89.71%
EBIT growth 5Y30.47%
EBIT Next Year-27.61%
EBIT Next 3Y1.21%
EBIT Next 5YN/A
FCF growth 1Y1102.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y89.73%
OCF growth 3YN/A
OCF growth 5YN/A

CERAGON NETWORKS LTD / CRNT Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CERAGON NETWORKS LTD (CRNT) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CRNT.


What is the valuation status for CRNT stock?

ChartMill assigns a valuation rating of 6 / 10 to CERAGON NETWORKS LTD (CRNT). This can be considered as Fairly Valued.


What is the profitability of CRNT stock?

CERAGON NETWORKS LTD (CRNT) has a profitability rating of 4 / 10.


Can you provide the financial health for CRNT stock?

The financial health rating of CERAGON NETWORKS LTD (CRNT) is 3 / 10.


Can you provide the expected EPS growth for CRNT stock?

The Earnings per Share (EPS) of CERAGON NETWORKS LTD (CRNT) is expected to grow by 65.75% in the next year.